(S,R,S)-AHPC-PEG2-NH2 dihydrochloride
CAS No. 2341796-76-5
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride ( VH032-PEG2-NH2 dihydrochloride; VH032-linker 12; VH032 amide-PEG2-amine )
产品货号. M27014 CAS No. 2341796-76-5
(S,R,S)-AHPC-PEG2-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥275 | 有现货 |
|
10MG | ¥446 | 有现货 |
|
25MG | ¥915 | 有现货 |
|
50MG | ¥1442 | 有现货 |
|
100MG | ¥2066 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(S,R,S)-AHPC-PEG2-NH2 dihydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(S,R,S)-AHPC-PEG2-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker.
-
产品描述(S,R,S)-AHPC-PEG2-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker.(In Vitro):PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
同义词VH032-PEG2-NH2 dihydrochloride; VH032-linker 12; VH032 amide-PEG2-amine
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2341796-76-5
-
分子量648.6
-
分子式C28H43Cl2N5O6S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C([C@H]1N(C([C@@H](NC(COCCOCCN)=O)C(C)(C)C)=O)C[C@H](O)C1)NCC2=CC=C(C3=C(C)N=CS3)C=C2.Cl.Cl
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sagong HY, Kim KJ. Structural Insights into Substrate Specificity of Cystathionine γ-Synthase from Corynebacterium glutamicum. J Agric Food Chem. 2017 Jul 26;65(29):6002-6008.
产品手册
关联产品
-
(+)-Isopulegol
(+)-Isopulegol is a monoterpenoid from Mentha canadensis L.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
Brandioside
Brandioside shows strong antioxidant, and neuroprotective effects, it significantly attenuates glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 microM; it exhibits significant inhibition of advanced glycation end product formation with the IC50 value of 4.6-25.7 μM.